Selected research
Industry Research
Granisetron Base Industry Research Report 2026
Market perspective
The global Granisetron Base market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Granisetron Base is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Granisetron Base is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Granisetron Base is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Granisetron Base include Apotex, ARK PHA.LTD, Cipla, Dr Reddy's Laboratories, Hansoh Pharma, Jishengtang Pharma, Luoxin, Wavelength Pharmaceuticals and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Granisetron Base market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Granisetron Base Market by Company
Apotex
ARK PHA.LTD
Cipla
Dr Reddy's Laboratories
Hansoh Pharma
Jishengtang Pharma
Luoxin
Wavelength Pharmaceuticals
Pfizer
Sandoz
Sun Pharmaceutical
Teva
Eisai
Granisetron Base Segment by Type
Capsule
Pill
Granisetron Base Segment by Application
Hospital
Pharmacy
Granisetron Base Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron Base market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Granisetron Base and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron Base.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Granisetron Base manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Granisetron Base by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Granisetron Base in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Pill
Applications
- Hospital
- Pharmacy
Companies covered
- Apotex
- ARK PHA.LTD
- Cipla
- Dr Reddy's Laboratories
- Hansoh Pharma
- Jishengtang Pharma
- Luoxin
- Wavelength Pharmaceuticals
- Pfizer
- Sandoz
- Sun Pharmaceutical
- Teva
- Eisai
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Granisetron Base Market Size (2021-2032)
- 2.2.2 Global Granisetron Base Sales (2021-2032)
- 2.2.3 Global Granisetron Base Market Average Price (2021-2032)
- 2.3 Granisetron Base by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Pill
- 2.4 Granisetron Base by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Granisetron Base Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Granisetron Base Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Granisetron Base Revenue of Manufacturers (2021-2026)
- 3.4 Global Granisetron Base Average Price by Manufacturers (2021-2026)
- 3.5 Global Granisetron Base Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Granisetron Base, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Granisetron Base, Product Type & Application
- 3.8 Global Manufacturers of Granisetron Base, Established Date
- 3.9 Global Granisetron Base Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Apotex
- 4.1.1 Apotex Company Information
- 4.1.2 Apotex Business Overview
- 4.1.3 Apotex Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Apotex Granisetron Base Product Portfolio
- 4.1.5 Apotex Recent Developments
- 4.2 ARK PHA.LTD
- 4.2.1 ARK PHA.LTD Company Information
- 4.2.2 ARK PHA.LTD Business Overview
- 4.2.3 ARK PHA.LTD Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ARK PHA.LTD Granisetron Base Product Portfolio
- 4.2.5 ARK PHA.LTD Recent Developments
- 4.3 Cipla
- 4.3.1 Cipla Company Information
- 4.3.2 Cipla Business Overview
- 4.3.3 Cipla Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cipla Granisetron Base Product Portfolio
- 4.3.5 Cipla Recent Developments
- 4.4 Dr Reddy's Laboratories
- 4.4.1 Dr Reddy's Laboratories Company Information
- 4.4.2 Dr Reddy's Laboratories Business Overview
- 4.4.3 Dr Reddy's Laboratories Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Dr Reddy's Laboratories Granisetron Base Product Portfolio
- 4.4.5 Dr Reddy's Laboratories Recent Developments
- 4.5 Hansoh Pharma
- 4.5.1 Hansoh Pharma Company Information
- 4.5.2 Hansoh Pharma Business Overview
- 4.5.3 Hansoh Pharma Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hansoh Pharma Granisetron Base Product Portfolio
- 4.5.5 Hansoh Pharma Recent Developments
- 4.6 Jishengtang Pharma
- 4.6.1 Jishengtang Pharma Company Information
- 4.6.2 Jishengtang Pharma Business Overview
- 4.6.3 Jishengtang Pharma Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jishengtang Pharma Granisetron Base Product Portfolio
- 4.6.5 Jishengtang Pharma Recent Developments
- 4.7 Luoxin
- 4.7.1 Luoxin Company Information
- 4.7.2 Luoxin Business Overview
- 4.7.3 Luoxin Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Luoxin Granisetron Base Product Portfolio
- 4.7.5 Luoxin Recent Developments
- 4.8 Wavelength Pharmaceuticals
- 4.8.1 Wavelength Pharmaceuticals Company Information
- 4.8.2 Wavelength Pharmaceuticals Business Overview
- 4.8.3 Wavelength Pharmaceuticals Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Wavelength Pharmaceuticals Granisetron Base Product Portfolio
- 4.8.5 Wavelength Pharmaceuticals Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Granisetron Base Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Sandoz
- 4.10.1 Sandoz Company Information
- 4.10.2 Sandoz Business Overview
- 4.10.3 Sandoz Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sandoz Granisetron Base Product Portfolio
- 4.10.5 Sandoz Recent Developments
- 4.11 Sun Pharmaceutical
- 4.11.1 Sun Pharmaceutical Company Information
- 4.11.2 Sun Pharmaceutical Business Overview
- 4.11.3 Sun Pharmaceutical Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sun Pharmaceutical Granisetron Base Product Portfolio
- 4.11.5 Sun Pharmaceutical Recent Developments
- 4.12 Teva
- 4.12.1 Teva Company Information
- 4.12.2 Teva Business Overview
- 4.12.3 Teva Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Granisetron Base Product Portfolio
- 4.12.5 Teva Recent Developments
- 4.13 Eisai
- 4.13.1 Eisai Company Information
- 4.13.2 Eisai Business Overview
- 4.13.3 Eisai Granisetron Base Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Eisai Granisetron Base Product Portfolio
- 4.13.5 Eisai Recent Developments
5 Global Granisetron Base Market Scenario by Region
- 5.1 Global Granisetron Base Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Granisetron Base Sales by Region: 2021-2032
- 5.2.1 Global Granisetron Base Sales by Region: 2021-2026
- 5.2.2 Global Granisetron Base Sales by Region: 2027-2032
- 5.3 Global Granisetron Base Revenue by Region: 2021-2032
- 5.3.1 Global Granisetron Base Revenue by Region: 2021-2026
- 5.3.2 Global Granisetron Base Revenue by Region: 2027-2032
- 5.4 North America Granisetron Base Market Facts & Figures by Country
- 5.4.1 North America Granisetron Base Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Granisetron Base Sales by Country (2021-2032)
- 5.4.3 North America Granisetron Base Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Granisetron Base Market Facts & Figures by Country
- 5.5.1 Europe Granisetron Base Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Granisetron Base Sales by Country (2021-2032)
- 5.5.3 Europe Granisetron Base Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Granisetron Base Market Facts & Figures by Country
- 5.6.1 Asia Pacific Granisetron Base Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Granisetron Base Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Granisetron Base Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Granisetron Base Market Facts & Figures by Country
- 5.7.1 South America Granisetron Base Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Granisetron Base Sales by Country (2021-2032)
- 5.7.3 South America Granisetron Base Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Granisetron Base Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Granisetron Base Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Granisetron Base Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Granisetron Base Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Granisetron Base Sales by Type (2021-2032)
- 6.1.1 Global Granisetron Base Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Granisetron Base Sales Market Share by Type (2021-2032)
- 6.2 Global Granisetron Base Revenue by Type (2021-2032)
- 6.2.1 Global Granisetron Base Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Granisetron Base Revenue Market Share by Type (2021-2032)
- 6.3 Global Granisetron Base Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Granisetron Base Sales by Application (2021-2032)
- 7.1.1 Global Granisetron Base Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Granisetron Base Sales Market Share by Application (2021-2032)
- 7.2 Global Granisetron Base Revenue by Application (2021-2032)
- 7.2.1 Global Granisetron Base Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Granisetron Base Revenue Market Share by Application (2021-2032)
- 7.3 Global Granisetron Base Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Granisetron Base Value Chain Analysis
- 8.1.1 Granisetron Base Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Granisetron Base Production Mode & Process
- 8.2 Granisetron Base Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Granisetron Base Distributors
- 8.2.3 Granisetron Base Customers
9 Global Granisetron Base Analyzing Market Dynamics
- 9.1 Granisetron Base Industry Trends
- 9.2 Granisetron Base Industry Drivers
- 9.3 Granisetron Base Industry Opportunities and Challenges
- 9.4 Granisetron Base Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst